The Clinical Decision Support App segmentation by application reveals five primary use‑cases that together drive the market’s revenue composition. Diagnosis support tools, which supply real‑time differential diagnosis suggestions, represent the largest slice, accounting for roughly 35 % of total spend due to high adoption in radiology and pathology departments. Treatment‑planning applications, delivering evidence‑based therapeutic pathways, follow at 25 %, reflecting strong demand in oncology and surgical specialties. Medication‑management solutions, focused on dosing alerts and drug‑interaction checks, capture 20 % of the market, propelled by regulatory mandates for safety. Predictive‑analytics apps, leveraging machine‑learning models to forecast patient outcomes, hold 12 % of the market, a segment growing rapidly as hospitals invest in population‑health initiatives. Finally, workflow‑optimization platforms, which streamline order sets and documentation, contribute the remaining 8 %, underscoring a niche but essential role in improving clinical efficiency. These application categories collectively shape the overall market size by dictating development priorities, pricing strategies, and investment flows.